✨ Free AI Report
INDIVIOR PLC: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research INDIVIOR PLC
Company Research

INDIVIOR PLC: Business Overview, Financials & Competitive Analysis

INDIVIOR PLC: A Remarkable Story of Innovation and Leadership in Addiction Treatment INDIVIOR PLC is a global pharmaceutical company committed to pioneering life-transforming treatments for addiction...

Analyst-debate audio for INDIVIOR PLC

AskCyborg analysts argue the bull and bear cases for INDIVIOR PLC across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Company OverviewProduct PortfolioLeadership and Management TeamFinancial OverviewMarketing StrategiesMarket Overview and Competitors
Get Interactive Report Freeor start reading below
Live on AskCyborg
7/10Solid
Indivior PLC

Indivior is leveraging operational efficiency and SUBLOCADE momentum to drive profitable growth in the high-value OUD treatment market.

▶︎ Listen to the 90-second analyst debate
Competitors covered:Hikma Pharmaceuticals PLC
7/ 10Solid

Cyborg Score thesis

Indivior is leveraging operational efficiency and SUBLOCADE momentum to drive profitable growth in the high-value OUD treatment...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals - Opioid Use Disorder Treatment
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: August 17, 2026
AI-Verified Research
30+ Page Report

Get the Latest INDIVIOR PLC Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

INDIVIOR PLC: A Remarkable Story of Innovation and Leadership in Addiction Treatment

INDIVIOR PLC is a global pharmaceutical company committed to pioneering life-transforming treatments for addiction and serious mental health conditions. With its headquarters in Richmond, Virginia, and listed on the London Stock Exchange, INDIVIOR PLC has earned a reputation for its innovative approach to healthcare. The company’s mission is to help patients reclaim their lives by delivering high-quality, evidence-based treatments.

Company Overview

Pro stress-test →

Founded in 2014 as a spin-off from Reckitt Benckiser, INDIVIOR PLC has quickly established itself as a leader in addiction treatment. The company focuses on developing medications that address opioid dependence, alcohol use disorder, and schizophrenia. INDIVIOR PLC’s commitment to research and development has resulted in a robust pipeline of products aimed at improving patient outcomes.

Product Portfolio

Pro stress-test →

INDIVIOR PLC’s product portfolio includes several market-leading medications: Suboxone® (buprenorphine and naloxone) is a key product used in the treatment of opioid dependence, available in both film and tablet forms. Sublocade® (buprenorphine extended-release) is an injectable formulation designed for monthly administration, offering a long-acting treatment option for patients with opioid use disorder. Perseris® (risperidone) is an extended-release injectable suspension for the treatment of schizophrenia. These products underscore INDIVIOR’s commitment to providing comprehensive solutions for addiction and mental health conditions.

Leadership and Management Team

Pro stress-test →

INDIVIOR PLC boasts a strong leadership team dedicated to driving the company’s mission forward:

  • Mark Crossley, CEO: With over 20 years of experience in the pharmaceutical industry, Mark Crossley has been instrumental in steering INDIVIOR towards sustained growth and innovation.
  • Shaun Thaxter, Former CEO: A founding member of INDIVIOR, Shaun Thaxter played a crucial role in establishing the company’s vision and strategic direction.
  • Jason Thompson, CFO: Jason brings extensive financial expertise, ensuring the company’s financial health and strategic investments.

Financial Overview

INDIVIOR PLC has demonstrated strong financial performance, with consistent revenue growth driven by its leading products. Key financial metrics include:

  • Revenue: The company reported revenues of $785 million in the last fiscal year, reflecting a steady increase in product sales.
  • Profit Margins: INDIVIOR has maintained healthy profit margins, driven by its high-value product portfolio.
  • R&D Investment: Significant investment in research and development, with over $200 million allocated annually to foster innovation.

Marketing Strategies

INDIVIOR PLC employs a multi-faceted marketing strategy to reach healthcare providers and patients:

  • Educational Initiatives: The company invests in educational programs to raise awareness about addiction and mental health, targeting both healthcare professionals and the general public.
  • Digital Marketing: Utilizing digital channels, INDIVIOR engages with its audience through online campaigns, social media, and targeted advertising.
  • Partnerships: Collaborations with healthcare organizations and advocacy groups enhance the company’s reach and impact.

Market Overview and Competitors

The addiction treatment market is highly competitive, with several key players vying for market share. INDIVIOR PLC competes with companies such as Alkermes, Inc., Braeburn Pharmaceuticals, and Titan Pharmaceuticals. Despite the competition, INDIVIOR’s strong product portfolio and innovative approach have positioned it as a leader in the market.

Sales Strategies

INDIVIOR PLC employs a comprehensive sales strategy to drive product adoption and revenue growth:

  • Direct Sales Force: A dedicated sales team engages with healthcare providers to promote the benefits of the company’s products.
  • Distributor Partnerships: Collaborations with pharmaceutical distributors ensure widespread availability of INDIVIOR’s medications.
  • Patient Assistance Programs: Initiatives to support patients who may struggle to afford treatment, improving access to care.

Technologies Utilized

INDIVIOR PLC leverages cutting-edge technologies to enhance its product offerings:

  • Extended-Release Formulations: Advanced drug delivery technologies ensure sustained release of medication, improving patient compliance and outcomes.
  • Digital Health Solutions: The company is exploring digital health tools to complement its medications, offering holistic treatment approaches.

HR Practices

INDIVIOR PLC’s human resources practices are focused on fostering a positive and inclusive work environment:

  • Employee Development: Comprehensive training and development programs to enhance employee skills and career growth.
  • Diversity and Inclusion: Initiatives to promote diversity and inclusion within the workforce, ensuring a supportive and equitable workplace.
  • Health and Wellbeing: Employee wellness programs aimed at supporting physical and mental health.

Corporate Responsibility

INDIVIOR PLC is committed to corporate social responsibility, with initiatives aimed at making a positive impact on society:

  • Community Engagement: Partnerships with community organizations to support addiction treatment and mental health services.
  • Sustainability Efforts: Environmentally sustainable practices in manufacturing and operations to reduce the company’s carbon footprint.
  • Patient Advocacy: Advocacy efforts to improve access to addiction treatment and mental health services.

Future Plans

Looking ahead, INDIVIOR PLC has ambitious plans to expand its product portfolio and enhance patient care:

  • Pipeline Development: Ongoing research and development efforts to bring new treatments to market, addressing unmet medical needs.
  • Geographic Expansion: Plans to expand the company’s presence in key international markets, increasing access to its medications.
  • Innovative Solutions: Continued investment in digital health and innovative treatment approaches to improve patient outcomes.

For those interested in a comprehensive analysis of INDIVIOR PLC, our detailed report covers all aspects of the company’s operations, financial performance, and strategic plans. Gain deeper insights into INDIVIOR’s market position, competitive landscape, and future growth prospects by subscribing to our service.


Get your comprehensive report on INDIVIOR PLC by subscribing now!

What the analysts stress-tested

The top findings that survived the multi-agent debate for INDIVIOR PLC.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when INDIVIOR PLC has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

SuboxoneBuprenorphine-naloxone combination for OUD treatmentMethadoneSynthetic opioid agonist for opioid dependence maintenanceGeneric BuprenorphineCost-effective buprenorphine formulations

Compare INDIVIOR PLC with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

INDIVIOR PLC operates in Specialty Pharmaceuticals - Opioid Use Disorder Treatment. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals - Opioid Use Disorder Treatment research →
NEW · MCP server

Ask your AI assistant about INDIVIOR PLC

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare INDIVIOR PLC and its top competitor on Cyborg Score”
“What did INDIVIOR PLC do this quarter?”
“Is INDIVIOR PLC a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does INDIVIOR PLC do?+
INDIVIOR PLC: A Remarkable Story of Innovation and Leadership in Addiction Treatment INDIVIOR PLC is a global pharmaceutical company committed to pioneering life-transforming treatments for addiction...
What is INDIVIOR PLC's Cyborg Score?+
INDIVIOR PLC has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are INDIVIOR PLC's main competitors?+
Named competitors include Suboxone, Methadone, Generic Buprenorphine. The full competitive landscape is in the AskCyborg report.
How can I get the full INDIVIOR PLC research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the INDIVIOR PLC research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track INDIVIOR PLC over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Company Research

Gambling and Lotteries Industry BriefingStationery and Office Products Industry BriefingDefense Tech Industry BriefingAi Infrastructure Systems Industry BriefingPet Insurance Industry BriefingSelf-Storage Industry BriefingMetal Additive Manufacturing Industry BriefingAi Accelerator Hardware Systems Industry BriefingLuxury Wines & Spirits Industry BriefingEnzymatic Plastic Recycling Industry BriefingInfrastructure as a Service (IaaS) Industry Briefingluxury fashion apparel Industry Briefing

Explore Industry Research

Travel Insurance Industry Company Research ReportSecurity Services Industry Company Research ReportLandscaping and Grounds Maintenance Industry Company Research ReportJanitorial and Cleaning Services Industry Company Research ReportSustainability Consulting Industry Company Research ReportReal Estate Investment Trusts (REITs) Industry Company Research Report
Browse All Company ResearchBrowse All Industry ResearchRSS Feed